Virtual Reality Intervention for Fear of Heights
Launched by BOSTON UNIVERSITY CHARLES RIVER CAMPUS · Jun 16, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how listening to enjoyable background music while using virtual reality (VR) can help reduce fear of heights, also known as acrophobia. The study aims to see if this music makes the VR experience more effective for those who are afraid of heights, helping them feel less anxious when exposed to heights in a safe environment.
To be eligible for this trial, participants must be at least 18 years old, currently attend Boston University, and be able to read English to give informed consent. They should also be comfortable using a computer or touchscreen device. Additionally, participants need to have a certain level of fear of heights as measured by a questionnaire. If you choose to participate, you can expect to engage in VR activities designed to help manage your fear, all while listening to music that you enjoy. Please note that if you've participated in this study before, you won't be able to join again.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-report of 18 years of age or older
- • Current student at Boston University
- • Ability to read English to provide informed consent
- • Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet)
- • For Phase 2: Acrophobia score of ≥ 45.45 on the Acrophobia Questionnaire (AQ) Anxiety Subscale
- Exclusion Criteria:
- • Previous participation (i.e. no participant may take the survey more than once).
About Boston University Charles River Campus
Boston University Charles River Campus is a prominent academic institution dedicated to advancing health and science through innovative research and education. As a sponsor of clinical trials, the campus leverages its extensive resources and interdisciplinary expertise to facilitate groundbreaking studies that aim to improve patient outcomes and contribute to the understanding of various medical conditions. With a commitment to ethical research practices and collaboration with healthcare professionals, Boston University Charles River Campus plays a vital role in translating scientific discoveries into clinical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Laura Long, PhD
Principal Investigator
Boston University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported